[HTML][HTML] Phase I study of a combination of fluvastatin and celecoxib in children with relapsing/refractory low-grade or high-grade glioma (FLUVABREX)
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - Cancers, 2023 - mdpi.com
Simple Summary This study tested the repurposing of two rationally selected, non-
anticancer drugs as a way to address the need for less toxic therapeutic options in children …
anticancer drugs as a way to address the need for less toxic therapeutic options in children …
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - Cancers, 2023 - europepmc.org
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - …, 2023 - search.proquest.com
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: This study tested the repurposing of two rationally selected, non-
anticancer drugs as a way to address the need for less toxic therapeutic options in children …
anticancer drugs as a way to address the need for less toxic therapeutic options in children …
[HTML][HTML] Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - Cancers, 2023 - ncbi.nlm.nih.gov
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory
Low-Grade or High-Grade Glioma (FLUVABREX) - PMC Back to Top Skip to main content …
Low-Grade or High-Grade Glioma (FLUVABREX) - PMC Back to Top Skip to main content …
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).
P Leblond, E Tresch-Bruneel, A Probst, N Néant… - Cancers, 2023 - europepmc.org
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …
grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of …